The Injective platform continues to evolve, introducing new features and strengthening its position in the DeFi sector. This overview examines the key updates and achievements of the project.
Technological Updates of Injective
Injective has launched the Mainnet 2.0 update, which enhances transaction execution speed and platform security. It now supports seamless asset transfers using the Peggy 2.0 bridge, interacting with Ethereum, Solana, and Cosmos without intermediaries.
New Financial Instruments and Services
The platform introduced a new derivatives module that allows trading of tokenized treasury notes and credit products. Implemented features like zero-knowledge proofs ensure privacy for trading operations.
Team Growth and Financial Support
The Injective Labs team now has over 50 members, including former professionals from centralized exchanges and fintech startups. Investors such as Jump Trading, Binance Labs, and Pantera Capital continue to support the project, and the total allocated funds for developer incentives have exceeded $100 million.
Injective demonstrates significant progress in developing its platform, introducing new technologies and expanding its team, which may further impact growth and innovation in the DeFi space.
